PRESS RELEASE published on 02/28/2024 at 07:30, 1 year 10 months ago Scout24 ends FY2023 with 14% revenue growth and 21% ooEBITDA growth resulting in 60% margin – expecting continued growth and operating leverage in 2024 Scout24 reports strong FY2023 results with 14% revenue growth, 21% ooEBITDA growth, and 60% margin. Anticipates growth in 2024 amid market shifts. Q4 shows double-digit revenue growth and continued demand for core products Revenue Growth Scout24 FY2023 Results OoEBITDA Growth Market Shifts
PRESS RELEASE published on 02/28/2024 at 07:30, 1 year 10 months ago Flughafen Wien AG announces successful results in 2023 Flughafen Wien AG reports successful 2023 results with revenue and earnings growth, investments doubling to over €200 million, positive outlook for 2024, and expansion plans including new jobs and infrastructure projects Revenue Growth 2023 Results Earnings Increase Flughafen Wien AG Investment Doubling
PRESS RELEASE published on 02/28/2024 at 07:30, 1 year 10 months ago AUTO1 Group reports record gross profit in 2023 and best annual adjusted EBITDA since IPO AUTO1 Group SE reports record gross profit and best ever annual adjusted EBITDA in 2023, highlighting strong financial results for the full year and Q4. CEO and CFO optimistic about future growth and profitability Financial Results Adjusted EBITDA 2023 AUTO1 Group SE Record Gross Profit
PRESS RELEASE published on 02/28/2024 at 07:10, 1 year 10 months ago Publication of unaudited financial statements of Kinarus Therapeutics Holding AG (only) for FY2023 Kinarus Therapeutics Holding AG releases unaudited financial statements for FY2023 in advance of extraordinary general meeting regarding Business Combination with Curatis AG. Implementation ongoing with expected closing in April 2024 Business Combination Kinarus Therapeutics Holding AG Curatis AG Unaudited Financial Statements FY2023
PRESS RELEASE published on 02/28/2024 at 07:00, 1 year 10 months ago Cicor acquires Evolution Medtec Srl and strengthens its engineering capabilities in the Medtech sector Cicor acquires Evolution Medtec Srl, strengthening engineering capabilities in the Medtech sector. The acquisition expands Cicor's expertise in medical technology market Acquisition Cicor Evolution Medtec Srl Engineering Capabilities Medtech Sector
REGULATED PRESS RELEASE published on 02/28/2024 at 07:00, 1 year 10 months ago Résultats 2023 : Marge opérationnelle courante : 20 %. Marge nette : 15 %. Dividende par action : +20 % Certidox annonce des résultats solides pour l'année 2023, avec une marge opérationnelle de 20% et une hausse de 20% du dividende par action. Prochains rendez-vous: AG des actionnaires le 16 avril 2024 Marge Opérationnelle Assemblée Générale Résultats 2023 Certidox Dividende Par Action
REGULATED PRESS RELEASE published on 02/28/2024 at 07:00, 1 year 10 months ago 2023 results: Current operating margin: 20%. Net margin: 15%. Dividend per share: +20% Interparfums reports strong financial performance in 2023 with operating margin at 20% and net margin at 15%. Dividend per share increased by 20% Financial Performance Interparfums Operating Margin Net Margin Dividend Per Share
PRESS RELEASE published on 02/28/2024 at 06:59, 1 year 10 months ago Zehnder Group achieves sales of EUR 762.1 million with an EBIT margin of 7.9% Zehnder Group reports EUR 762.1 million in sales and 7.9% EBIT margin for 2023, proposes CHF 1.30 dividend per share. Read more: https://documents.zehndergroup.com/ar-2023-en Financial Results Sales Dividend EBIT Margin Zehnder Group
PRESS RELEASE published on 02/28/2024 at 06:45, 1 year 10 months ago Financial year 2023 - Targets achieved, on track for sustainably profitable growth Implenia AG achieves financial targets for 2023, with EBIT at CHF 122.6 million, consolidated profit hits record high. Sustainability Report highlights commitment to sustainable practices. Aiming for EBIT of CHF 130 million in 2024 Sustainability Financial Targets EBIT 2024 Implenia AG
PRESS RELEASE published on 02/28/2024 at 06:45, 1 year 10 months ago Exercice 2023 : objectifs atteints ; en bonne voie pour une croissance rentable et durable Implenia AG atteint ses objectifs annuels en 2023 avec un EBIT de CHF 122,6 millions et un résultat consolidé record de CHF 141,8 millions. Le groupe se concentre sur une croissance rentable et durable Objectifs Annuels Croissance Durable EBIT Implenia AG Résultat Consolidé
Published on 01/02/2026 at 19:50, 2 hours 37 minutes ago Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+
Published on 01/02/2026 at 15:00, 7 hours 27 minutes ago Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Published on 01/02/2026 at 14:00, 8 hours 27 minutes ago Metallic Minerals Provides Corporate Update and Responds to Recent Market Activity
Published on 01/02/2026 at 13:10, 9 hours 17 minutes ago Organto Foods Inc. Announces Proposed Early Warrant Exercise Incentive
Published on 01/02/2026 at 13:00, 9 hours 27 minutes ago Golden Minerals Company Substantially Reduces Liabilities in Mexico
Published on 01/02/2026 at 21:29, 57 minutes ago Crédit Mutuel Alliance Fédérale completes the acquisition of OLB and scales up in Germany
Published on 01/02/2026 at 18:55, 3 hours 32 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 01/02/2026 at 18:43, 3 hours 44 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/02/2026 at 18:25, 4 hours 2 minutes ago Bitmine Publishes New Chairman's Message Explaining Why Shareholders Should Vote YES to Approve the Amendment to Increase Authorized Shares
Published on 01/02/2026 at 17:45, 4 hours 42 minutes ago Mise en ligne du document « Pre-FY 2025 Results Communication »
Published on 01/02/2026 at 17:45, 4 hours 42 minutes ago Availability of the Pre-FY 2025 Results Communication
Published on 12/29/2025 at 19:14, 4 days 3 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 22 au 26 décembre 2025 dans le cadre du programme de rachat d’actions.
Published on 12/29/2025 at 18:05, 4 days 4 hours ago Covivio - Déclaration des transactions sur actions propres réalisées du 22 décembre au 24 décembre 2025
Published on 12/29/2025 at 18:05, 4 days 4 hours ago Covivio - Treasury shares transactions between December 22nd , 2025 and December 24th, 2025